checkAd

    EQS-Adhoc  109  0 Kommentare Vitruvia Medical AG: Consolidated interim results as per June 30th,2023

    Für Sie zusammengefasst
    • Vitruvia Medical AG achieves expected results in H1 2023.
    • Consolidated revenues of approximately EUR 855,000.00 in H1 2023.
    • Management confirms outlook for full year with revenues of EUR 1.8 million.

    EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Half Year Results/Half Year Report
    Vitruvia Medical AG: Consolidated interim results as per June 30th,2023

    29-Sep-2023 / 12:15 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    Consolidated interim results as per June 30th,2023

    Vitruvia Medical AG achieves results as expected in the first half of 2023. The Board of Directors confirms the guidance for the full year.

    Vitruvia Medical AG is on target in the first six months of 2023. The company generated consolidated revenues of approximately EUR 855,000.00 in the first half of 2023, with earnings before interest, taxes, depreciation and amortization of EUR -176,884.00.

    Based on the results for the first half of 2023, which were as expected, the management confirms the outlook for the current full year. For this period, the Board of Directors expects consolidated revenues of approximately EUR 1.8 million. On a consolidated basis, Vitruvia Medical AG anticipates a further improvement in earnings compared to the previous year, which will, however, still be in negative territory.

     



    End of Inside Information

    29-Sep-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com

    Language: English
    Company: Vitruvia Medical AG
    Kesselackerstr. 18
    5611 Anglikon
    Switzerland
    Phone: +41 44 915 33 78
    E-mail: kontakt@vitruvia-med.com
    Internet: www.vitruvia-med.com
    ISIN: CH0461931419
    WKN: A2PDWF
    Listed: Regulated Unofficial Market in Munich
    EQS News ID: 1738073

     
    End of Announcement EQS News Service

    1738073  29-Sep-2023 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1738073&application_name=news&site_id=wallstreet

    Lesen Sie auch




    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-Adhoc Vitruvia Medical AG: Consolidated interim results as per June 30th,2023 EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Half Year Results/Half Year Report Vitruvia Medical AG: Consolidated interim results as per June 30th,2023 29-Sep-2023 / 12:15 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of …